NR4A1 and neoplasm: The better prognosis in TC of the breast may be related to the special clinicopathologic features, including small tumor size, node-negative, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, and lower tumor grade disease (1, 5–8).